: (A) Analysis at confocal microscopy of HUVECs treated, for 1 and 3 hours, with 20 μg/ml (Exo 20 μg/ ml) and 50 μg/ml (Exo 50 μg/ml) of LAMA84 exosomes, compared with HUVECs treated, for 3 hours, with 20 μg/ml (Curcu-Exo 20 μg/ ml) and 50 μg/ml (Curcu-Exo 50 μg/ml) of exosomes released from LAMA84 treated with 20 µM Curcumin. HUVECs were stained with ActinGreen (green), nuclear counterstaining was performed using Hoescht (blue); exosomes were labelled with PKH26 (red). (B) The semi-quantitative analysis of K562 exosomes internalization, measured as red fluorescence intensity in the cytoplasm of HUVECs. (C) The semi-quantitative analysis of LAMA84 exosomes internalization, measured as red fluorescence intensity in the cytoplasm of HUVECs.
Values are the mean ± SD of 3 fields in three independent experiments *p ≤ 0.05, **p ≤ 0.01. The migration ability of HUVECs transfected with miR-21 inhibitor (2-Ome-miR-21) and treated or not with 20 μg/ml of LAMA84 control and Curcu-exosomes (2-Ome-miR-21 + Exo 20 μg/ml) and in HUVECs transfected with miR-21 mimic (miR-21 mimic) and treated or not with 20 μg/ml of exosomes (miR-21 mimic + Exo 20 μg/ml) was also evaluated. (B) Treatment of HUVECs with Curcu-Exosomes modulated IL8 expression. Real time PCR analysis showed that IL8 mRNA expression in dose dependent manner in HUVECs after addition of Curcu-exosomes compared to control exosomes. (C) ELISA assay showed that IL8 protein expression decreased in EC treated with Curcu-exosomes compared to control exosomes, in dose dependent manner.
